Detalles de la búsqueda
1.
Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study.
BMC Med
; 20(1): 433, 2022 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36352410
2.
Shift in harms and benefits of cervical cancer screening in the era of HPV screening and vaccination: a modelling study.
BJOG
; 129(11): 1862-1869, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429107
3.
Effects of cancer screening restart strategies after COVID-19 disruption.
Br J Cancer
; 124(9): 1516-1523, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33723386
4.
Reducing unnecessary referrals for colposcopy in hrHPV-positive women within the Dutch cervical cancer screening programme: A modelling study.
Gynecol Oncol
; 160(3): 713-720, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33451725
5.
The optimal HPV-screening protocol in Eastern-Europe: The example of Slovenia.
Gynecol Oncol
; 160(1): 118-127, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33199028
6.
Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis.
Prev Med
; 151: 106623, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34029578
7.
Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy.
Acta Obstet Gynecol Scand
; 98(6): 737-746, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30687935
8.
Correction: Effects of cancer screening restart strategies after COVID-19 disruption.
Br J Cancer
; 125(1): 145, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33976368
9.
A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions.
Elife
; 112022 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36222673
10.
Health impacts of COVID-19 disruptions to primary cervical screening by time since last screen: A model-based analysis for current and future disruptions.
medRxiv
; 2022 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35923317
11.
Risk of Gynecologic Cancer after Atypical Glandular Cells Found on Cervical Cytology: A Population-Based Cohort Study.
Cancer Epidemiol Biomarkers Prev
; 30(4): 743-750, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563645
12.
Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
JAMA Oncol
; 7(6): 885-894, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914025
13.
Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe.
MDM Policy Pract
; 6(1): 2381468320984974, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33598546
14.
The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe.
Prev Med Rep
; 22: 101392, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34026466
15.
Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review.
Eur J Cancer
; 127: 207-223, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31980322
16.
Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review.
Eur J Cancer
; 127: 191-206, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31932175
17.
Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review.
Eur J Cancer
; 127: 224-235, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31932176
18.
Response to the letter commenting on 'Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review'.
Eur J Cancer
; 138: 232-233, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32811688
Resultados
1 -
18
de 18
1
Próxima >
>>